在基因组编辑和治疗的工程病毒样粒子方面取得了进展
Se Hyeok Son1, Seeone Woo1, Ayeon Choi1
1College of Pharmacy, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul, 06974, South Korea.
概括
工程病毒样粒子 (eVLP) 提供安全和高效的基因组编辑工具,如CRISPR-Cas9. 这些先进的eVLP显示出治疗遗传疾病的前景,并正在向临床应用迈进.
科学领域:
- 生物技术是生物技术.
- 基因治疗 基因治疗
- 分子生物学分子生物学
背景情况:
- 工程病毒样粒子 (eVLP) 正在成为基因组编辑技术的先进交付系统.
- 它们将病毒载体进入效率与非病毒平台安全性相结合,用于短暂输送核糖蛋白 (例如,Cas9,基编辑器,主要编辑器).
研究的目的:
- 审查eVLP在基因组编辑应用中的原理,进展和治疗潜力.
- 讨论基于eVLP的基因编辑疗法的挑战和未来方向.
主要方法:
- 简要介绍eVLP的结构和生产原理.
- 关于eVLP设计和工程的关键发展进展的调查.
- 对细胞类型特定向的伪型化策略的分析.
主要成果:
- 理性工程和定向优化改善了eVLP组装,货物的稳定性和编辑效率.
- 伪造型增强了针对性交付的eVLP多功能性.
- 临床前研究表明,eVLP在单一性和复杂疾病模型中的潜力.
结论:
- 电子遗传编辑器 (eVLP) 是一种有前途的基因组编辑剂暂时输送平台.
- 在eVLP技术的进步支持他们的进展向临床翻译各种遗传疾病.
- 需要进一步开发以应对治疗应用中的未来挑战.
更多相关视频
06:10Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
995
10:42A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells
Published on: December 12, 2017
16.3K
相关概念视频
CRISPR/Cas9 Genome Editing
2.1K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.1K
CRISPR
58.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.2K
Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Gene Therapy
27.8K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.8K
What is Genetic Engineering?
80.6K
Overview
80.6K
